Recruiting Master's and Doctoral Researchers for Drug Development and Research into Treatments for Intractable Diseases

Artificial intelligence (AI) company Aseuteoromopeu announced on November 13 that it is recruiting additional biology researchers with master's or doctoral degrees to conduct drug development and research into treatments for intractable diseases at its in-house wet lab. Newly hired researchers will work with the AI research team to refine research hypotheses and design and conduct experiments to test them.


Aseuteoromopeu recently opened its in-house wet lab and began biological research and experimental validation. Each program is overseen by a research lead known as a "Scientific Manager." The company plans to hire additional Scientific Managers and research staff who will conduct experiments and analyze the results.

Aseuteoromopeu Expands Hiring of Biologists to Test AI Hypotheses View original image

Applicants must hold a master's or doctoral degree in a related field, such as life sciences, biotechnology, pharmacy, or veterinary medicine, and have experience with cell-based and animal-model experiments. Hired researchers will take part in experimental validation for AI-based scientific research, primarily at the company's in-house wet lab.


Aseuteoromopeu said it places greater emphasis on researchers' problem-solving abilities and capacity to conduct research independently than on simply expanding its hiring numbers. In particular, it is seeking candidates who can draw on their specialized knowledge and practical experience to take the lead in resolving problems that arise during research and advance new research methodologies.



Lee Minhyung, CEO of Aseuteoromopeu, said, "To drive research innovation through scientific superintelligence, scientists who can apply AI advances in real-world research settings have an important role to play. We will create an environment where outstanding biology researchers with expertise in their respective fields can work closely with AI specialists."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing